{{Rsnum
|rsid=3213182
|Gene=E2F1
|Chromosome=20
|position=33675427
|Orientation=minus
|GMAF=0.045
|Gene_s=E2F1,NECAB3
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 0.9 | 15.0 | 84.1
| HCB | 0.0 | 0.0 | 100.0
| JPT | 0.0 | 0.0 | 100.0
| YRI | 0.0 | 0.0 | 100.0
| ASW | 0.0 | 7.0 | 93.0
| CHB | 0.0 | 0.0 | 100.0
| CHD | 0.0 | 0.9 | 99.1
| GIH | 0.0 | 10.9 | 89.1
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 12.1 | 87.9
| MKK | 0.0 | 1.3 | 98.7
| TSI | 0.0 | 24.5 | 75.5
| HapMapRevision=28
}}{{PMID Auto
|PMID=23255957
|Title=Functional variants at the miRNA binding sites of the E2F1 gene and its mRNA expression
|OA=1
}}

{{PMID Auto
|PMID=18488026
|Title=Common sequence variants on 20q11.22 confer melanoma susceptibility.
|OA=1
}}

{{PMID Auto
|PMID=22344756
|Title=Combined effects of E2F1 and E2F2 polymorphisms on risk and early onset of squamous cell carcinoma of the head and neck.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}